A phase II trial of ruxolitinib in combination with azacytidine in myelodysplastic syndrome/myeloproliferative neoplasms-Reference-Cited by-同舟云学术

A phase II trial of ruxolitinib in combination with azacytidine in myelodysplastic syndrome/myeloproliferative neoplasms

Published:2017-11-27 Issue:2 Volume:93 Page:277-285
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:Am J Hematol

Author:

Assi Rita¹^ORCID,Kantarjian Hagop M.¹^ORCID,Garcia-Manero Guillermo¹,Cortes Jorge E.¹,Pemmaraju Naveen¹^ORCID,Wang Xuemei²,Nogueras-Gonzalez Graciela²,Jabbour Elias¹^ORCID,Bose Prithviraj¹,Kadia Tapan¹^ORCID,Dinardo Courtney D.¹^ORCID,Patel Keyur³,Bueso-Ramos Carlos³,Zhou Lingsha¹,Pierce Sherry¹,Gergis Romany¹,Tuttle Carla¹,Borthakur Gautam¹,Estrov Zeev¹,Luthra Rajyalakshmi³,Hidalgo-Lopez Juliana³^ORCID,Verstovsek Srdan¹,Daver Naval¹^ORCID

Affiliation:

1. Department of Leukemia; The University of Texas MD Anderson Cancer Center; Houston Texas

2. Department of Biostatistics; The University of Texas MD Anderson Cancer Center; Houston Texas

3. Department of Hematopathology; The University of Texas MD Anderson Cancer Center; Houston Texas

Funder

Incyte Pharmaceuticals

Cancer Centre Leukaemia Support Grant

University of Texas MD Anderson Cancer Center

Charif Souki Cancer Research Fund and generous philanthropic contributions to the MD Anderson Moon Shots Program

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/ajh.24972/fullpdf

Reference59 articles.

1. The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes;Vardiman;Blood.,2009

2. An International MDS/MPN Working Group's perspective and recommendations on molecular pathogenesis, diagnosis and clinical characterization of myelodysplastic/myeloproliferative neoplasms;Mughal;Haematologica.,2015

3. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia;Arber;Blood.,2016

4. The myelodysplastic/myeloproliferative neoplasms: myeloproliferative diseases with dysplastic features;Orazi;Leukemia.,2008

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Atypical CML: Diagnosis and Therapy;Clinical Lymphoma Myeloma and Leukemia;2024-09

2. Chronic Myelomonocytic Leukemia and Atypical Chronic Myeloid Leukemia: A National Analysis;Clinical Lymphoma Myeloma and Leukemia;2024-07

3. Management of adult patients with CMML undergoing allo-HCT: recommendations from the EBMT PH&G Committee;Blood;2024-05-30

4. Chronic neutrophilic leukemia and atypical chronic myeloid leukemia: 2024 update on diagnosis, genetics, risk stratification, and management;American Journal of Hematology;2024-04-21

5. VEXAS and Myelodysplastic Syndrome: An Interdisciplinary Challenge;Journal of Clinical Medicine;2024-02-12